1. Home
  2. HOV vs PHAT Comparison

HOV vs PHAT Comparison

Compare HOV & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hovnanian Enterprises Inc.

HOV

Hovnanian Enterprises Inc.

N/A

Current Price

$104.65

Market Cap

592.5M

ML Signal

N/A

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

N/A

Current Price

$5.85

Market Cap

590.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HOV
PHAT
Founded
1959
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
592.5M
590.6M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
HOV
PHAT
Price
$104.65
$5.85
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $20.05
AVG Volume (30 Days)
106.9K
★ 1.7M
Earning Date
12-03-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 42.72
EPS
★ 1.55
N/A
Revenue
★ $2,978,581,000.00
$175,110,000.00
Revenue This Year
N/A
$79.63
Revenue Next Year
$4.52
$54.71
P/E Ratio
$64.32
★ N/A
Revenue Growth
N/A
★ 216.93
52 Week Low
$90.17
$5.02
52 Week High
$148.48
$18.31

Technical Indicators

Market Signals
Indicator
HOV
PHAT
Relative Strength Index (RSI) 49.94 34.30
Support Level $90.85 $5.02
Resistance Level $118.46 $7.72
Average True Range (ATR) 5.67 0.62
MACD 1.20 -0.06
Stochastic Oscillator 91.47 28.10

Price Performance

Historical Comparison
HOV
PHAT

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: